Bartlett NL - Search Results

1

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies.

Bartlett NL, Chen R, Fanale MA, Brice P, Gopal A, Smith SE, Advani R, Matous JV, Ramchandren R, Rosenblatt JD, Huebner D, Levine P, Grove L, Forero-Torres A. Bartlett NL, et al. J Hematol Oncol. 2014 Mar 19;7:24. doi: 10.1186/1756-8722-7-24. J Hematol Oncol. 2014. PMID: 24642247 Free PMC article. Clinical Trial.

2

Antibodies for the treatment of diffuse large cell lymphoma.

Blum KA, Bartlett NL. Blum KA, et al. Among authors: bartlett nl. Semin Oncol. 2003 Aug;30(4):448-56. doi: 10.1016/s0093-7754(03)00251-3. Semin Oncol. 2003. PMID: 12939713 Review.

3

New therapies in Hodgkin's lymphoma.

Bartlett N. Bartlett N. Clin Adv Hematol Oncol. 2004 Feb;2(2):80, 83. Clin Adv Hematol Oncol. 2004. PMID: 16163165 No abstract available.

4

Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.

Bartlett NL. Bartlett NL. Hematology Am Soc Hematol Educ Program. 2005:245-51. doi: 10.1182/asheducation-2005.1.245. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304388

5

A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies.

Bartlett NL, Younes A, Carabasi MH, Forero A, Rosenblatt JD, Leonard JP, Bernstein SH, Bociek RG, Lorenz JM, Hart BW, Barton J. Bartlett NL, et al. Blood. 2008 Feb 15;111(4):1848-54. doi: 10.1182/blood-2007-07-099317. Epub 2007 Dec 13. Blood. 2008. PMID: 18079362 Free PMC article. Clinical Trial.

6

Modern treatment of Hodgkin lymphoma.

Bartlett NL. Bartlett NL. Curr Opin Hematol. 2008 Jul;15(4):408-14. doi: 10.1097/MOH.0b013e328302c9d8. Curr Opin Hematol. 2008. PMID: 18536581 Review.

7

Salvage regimens for Hodgkin lymphoma.

Cashen AF, Bartlett NL. Cashen AF, et al. Among authors: bartlett nl. Clin Adv Hematol Oncol. 2008 Jul;6(7):517-24. Clin Adv Hematol Oncol. 2008. PMID: 18654119 Review.

8

A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.

Forero-Torres A, Leonard JP, Younes A, Rosenblatt JD, Brice P, Bartlett NL, Bosly A, Pinter-Brown L, Kennedy D, Sievers EL, Gopal AK. Forero-Torres A, et al. Among authors: bartlett nl. Br J Haematol. 2009 Jul;146(2):171-9. doi: 10.1111/j.1365-2141.2009.07740.x. Epub 2009 May 19. Br J Haematol. 2009. PMID: 19466965 Free article. Clinical Trial.

9

Anti-CD30 Antibodies for Hodgkin lymphoma.

Foyil KV, Bartlett NL. Foyil KV, et al. Among authors: bartlett nl. Curr Hematol Malig Rep. 2010 Jul;5(3):140-7. doi: 10.1007/s11899-010-0053-y. Curr Hematol Malig Rep. 2010. PMID: 20446121 Review.

10

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

Younes A, Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, Forero-Torres A. Younes A, et al. Among authors: bartlett nl. N Engl J Med. 2010 Nov 4;363(19):1812-21. doi: 10.1056/NEJMoa1002965. N Engl J Med. 2010. PMID: 21047225 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters